In the investigation of human and animal biology, the University of Queensland's Institute for Molecular Bioscience (IMB) generates a fund of ideas, many of which lend themselves to innovation and commercialisation. This process can lead to new medical treatments, highly valuable health diagnostic products and novel biomedical and other technologies. IMBcom is the value-adding innovation carrier for these ideas. We protect the discoveries of the IMB researchers, build alliances with organisations to promote them, and draw up partnerships with investors who help us to grow them into platforms for new enterprises.

The IMB's multi-disciplinary approach develops diverse programs combining research focused on bioinformatics, genomics, developmental biology, structural biology and drug design leading to outcomes of value to industry and the community. IMBcom is in the business of commercialising that biotechnology.